BCAB
Bioatla·NASDAQ
--
--(--)
--
--(--)
3.65 / 10
Netural
Analyst consensus is neutral (1 analyst), while fund‑flow sentiment is good with a 7.3/10 score. Small and medium investors show positive inflows; large and extra‑large investors are net outflows. Overall inflow ratio ~0.49, indicating modest buying pressure.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-08-13
InstitutionJMP Securities
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for BCAB?
- BCAB holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.65/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
